Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations

Giuseppe Murdaca; Giovanni Noberasco; Dario Olobardi; Claudio Lunardi; Matteo Maule; Lorenzo Delfino; Massimo Triggiani; Chiara Cardamone; Devis Benfaremo; Gianluca Moroncini; Angelo Vacca; Nicola Susca; Sebastiano Gangemi; Paola Quattrocchi; Laura Sticchi; Giancarlo Icardi; Andrea Orsi

doi:10.3390/vaccines9121426

Vaccines (Dec 2021)

Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations

Giuseppe Murdaca,
Giovanni Noberasco,
Dario Olobardi,
Claudio Lunardi,
Matteo Maule,
Lorenzo Delfino,
Massimo Triggiani,
Chiara Cardamone,
Devis Benfaremo,
Gianluca Moroncini,
Angelo Vacca,
Nicola Susca,
Sebastiano Gangemi,
Paola Quattrocchi,
Laura Sticchi,
Giancarlo Icardi,
Andrea Orsi

Affiliations

Giuseppe Murdaca: Departments of Internal Medicine, University of Genova, 16132 Genova, Italy
Giovanni Noberasco: Department of Health Sciences, University of Genova, 16132 Genova, Italy
Dario Olobardi: Department of Health Sciences, University of Genova, 16132 Genova, Italy
Claudio Lunardi: Department of Medicine, University of Verona, 37129 Verona, Italy
Matteo Maule: Department of Medicine, University of Verona, 37129 Verona, Italy
Lorenzo Delfino: Department of Medicine, University of Verona, 37129 Verona, Italy
Massimo Triggiani: Division of Allergy and Clinical Immunology, University of Salerno, 84084 Salerno, Italy
Chiara Cardamone: Division of Allergy and Clinical Immunology, University of Salerno, 84084 Salerno, Italy
Devis Benfaremo: Clinica Medica, Ospedali Riuniti Ancona, 60126 Ancona, Italy
Gianluca Moroncini: Clinica Medica, Ospedali Riuniti Ancona, 60126 Ancona, Italy
Angelo Vacca: “Guido Baccelli” Unit of Internal Medicine, Department of Biomedical Sciences and Human Oncology, School of Medicine, Aldo Moro University of Bari, 70121 Bari, Italy
Nicola Susca: “Guido Baccelli” Unit of Internal Medicine, Department of Biomedical Sciences and Human Oncology, School of Medicine, Aldo Moro University of Bari, 70121 Bari, Italy
Sebastiano Gangemi: Department of Clinical and Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, 98124 Messina, Italy
Paola Quattrocchi: Department of Clinical and Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, 98124 Messina, Italy
Laura Sticchi: Department of Health Sciences, University of Genova, 16132 Genova, Italy
Giancarlo Icardi: Department of Health Sciences, University of Genova, 16132 Genova, Italy
Andrea Orsi: Department of Health Sciences, University of Genova, 16132 Genova, Italy

DOI: https://doi.org/10.3390/vaccines9121426
Journal volume & issue: Vol. 9, no. 12
p. 1426

Abstract

Read online

Systemic sclerosis (SSc) is a rare autoimmune inflammatory rheumatic disease. The prevalence of SSc ranges from 7 to 700 cases per million worldwide. Due to multiple organ involvement and constant inflammatory state, this group of patients presents an increased risk of infectious diseases. This paper aimed to gather the up-to-date evidence on vaccination strategies for patients with SSc and to be a useful tool for the prevention and management of infectious diseases. The authors conducted a scoping review in which each paragraph presents data on a specific vaccine’s safety, immunogenicity, and efficacy. The work deals with the following topics: SARS-CoV-2, seasonal influenza, S. pneumoniae, HAV, HBV, HZV, N. meningitidis, H. influenzae, HPV, and diphtheria-tetanus-pertussis.

Published in Vaccines

ISSN: 2076-393X (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine
Website: http://www.mdpi.com/journal/vaccines

About the journal

Abstract

Keywords